In medicine, tools are increasingly being use to predict a patient’s symptom progression, identify individuals at risk, or to estimate the response...
On World Cancer Research Day, 24 September, we would like to highlight some of the most significant advances made over the past year by Clínic-IDIB...
A study led by professionals from the Clínic-IDIBAPS and the Barcelona Esquerra Primary Healthcare Consortium (CAPSBE) has developed a system for t...
RAS inhibitors have opened a new chapter in the treatment of pancreatic cancer, but some tumours develop resistance to these drugs. Here, we explor...
A study led by the Clínic-IDIBAPS provides new clues about the genetic basis of psychotic disorders such as schizophrenia and bipolar disorder. Th...
The Clínic-IDIBAPS has led the development of EBI-BD, a new open-access, interactive web platform that synthesizes all the available scientific evi...
Thomas Walle, head of the IDIBAPS Computational cancer biomedicine group has received a Starting Grant from the European Research Council (ERC) in...
A study led by the IDIBAPS Molecular genetics of paediatric lymphomas research group has identified genetic, biological and clinical differences b...
A study led by researchers from the Hospital Clínic-IDIBAPS, within the Clínic Barcelona Comprehensive Cancer Centre, has identified CD70 as a mark...
A study led by professionals from the Primary healthcare transversal research group at IDIBAPS and the Barcelona Esquerra Primary Healthcare Consor...
